Synmosa Biopharma Corp. engages in the manufacture and sale of ethical drug, over-the-counter drug, and healthcare products under Synmosa's trade mark. The firm's products include drugs for hormone replacement treatment, cardiovascular, neurology, urology, hormonal oncology, oral contraceptive, and over-the-counter products. It operates through the Active Pharmaceutical Ingredients and Generic Drugs segments. The company was founded on August 25, 1970 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company